Meridian Bioscience Inc expected to post earnings of 15cents a share - Earnings Preview

VivoPower

08/11/2022 14:47

* Meridian Bioscience Inc  VIVO.OQ   VIVO.O  is expected
to show a
fall in quarterly revenue when it reports  results on November
10 (estimated). 
    * The Cincinnati Ohio-based  company is expected to report 
a
11.5% decrease in revenue to $67.433 million from $76.2 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Meridian Bioscience
Inc
is for earnings of 15 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Meridian
Bioscience Inc is $34​, above​ its last closing price of $31.95.
​​​

This summary was machine generated November 8 at 14:47 GMT.  All
figures in US dollars  unless otherwise stated